ムコ多糖症I型(MPS I)(ハーラー症候群)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sanofi 30
Clinical Trial Overview of Sanofi 30
Nuo Therapeutics, Inc. 31
Clinical Trial Overview of Nuo Therapeutics, Inc. 31
ZonMw 32
Clinical Trial Overview of ZonMw 32
PTC Therapeutics, Inc. 33
Clinical Trial Overview of PTC Therapeutics, Inc. 33
Parkway Pantai Limited 34
Clinical Trial Overview of Parkway Pantai Limited 34
Multiplex Pharma Holdings LLC 35
Clinical Trial Overview of Multiplex Pharma Holdings LLC 35
Fate Therapeutics, Inc. 36
Clinical Trial Overview of Fate Therapeutics, Inc. 36
ArmaGen Technologies, Inc. 37
Clinical Trial Overview of ArmaGen Technologies, Inc. 37
Clinical Trial Overview of Top Institutes / Government 38
Masonic Cancer Center 38
Clinical Trial Overview of Masonic Cancer Center 38
Los Angeles Biomedical Research Institute 39
Clinical Trial Overview of Los Angeles Biomedical Research Institute 39
University of California, Los Angeles 40
Clinical Trial Overview of University of California, Los Angeles 40
Erasmus MC 41
Clinical Trial Overview of Erasmus MC 41
University of Texas Southwestern Medical Center at Dallas 42
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 42
University of Chicago 43
Clinical Trial Overview of University of Chicago 43
University Hospital Hamburg-Eppendorf 44
Clinical Trial Overview of University Hospital Hamburg-Eppendorf 44
University of Louisville 45
Clinical Trial Overview of University of Louisville 45
Emory University 46
Clinical Trial Overview of Emory University 46
University of Minnesota 47
Clinical Trial Overview of University of Minnesota 47
Five Key Clinical Profiles 48
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83